A5087202144- Renal and Vascular Pathologies
- Prostate Cancer Treatment and Research
- Cardiac, Anesthesia and Surgical Outcomes
- Enhanced Recovery After Surgery
- Ureteral procedures and complications
- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Diagnosis and Treatment
- Esophageal and GI Pathology
- Central Venous Catheters and Hemodialysis
- Statistical Methods in Clinical Trials
- Foreign Body Medical Cases
- Infectious Disease Case Reports and Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Urological Disorders and Treatments
- Urinary Bladder and Prostate Research
- Urologic and reproductive health conditions
- Renal cell carcinoma treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Colorectal Cancer Surgical Treatments
- Renal and related cancers
- Gender, Labor, and Family Dynamics
- Radiopharmaceutical Chemistry and Applications
- Cancer, Lipids, and Metabolism
- PARP inhibition in cancer therapy
- Urinary and Genital Oncology Studies
Jikei University School of Medicine
2024-2025
The University of Melbourne
2024-2025
Western Health
2022-2025
Footscray Hospital
2023-2024
St Vincent's Hospital
2024
Deakin University
2018
Background/Aim: The lung immune prognostic index (LIPI), which is determined by assessing the derived neutrophil-to-lymphocyte ratio in conjunction with level of lactate dehydrogenase, predicts outcomes various cancers. Its utility as a preoperative biomarker upper tract urothelial carcinoma (UTUC) patients remains unexplored. Patients and Methods: This retrospective study UTUC who underwent radical nephroureterectomy. were stratified into favorable, intermediate, poor LIPI groups....
To conduct a multi-institutional international survey to determine the clinical utility and applicability of nephrometry scoring systems in contemporary practice. Methods: A cross-sectional anonymous 15-item online was conducted on REDCap between January 2023 May 2023. Survey invitations were sent via email within Australia internationally urologists who are either members Urological Society New Zealand (USANZ) or Association Asia (UAA) have direct professional relationships with their...
To determine support for a tax on sugar-sweetened beverages (SSBs) among young Australian adults and the potential impact SSB consumption if is introduced.Cross-sectional convenience survey of Australians aged 18-30 years sampled in City Greater Geelong, Australia, November-December 2017.A total 1,793 responses were recorded. Overall, 48% supported SSBs, which increased to 74% 72% revenue was allocated subsidising fruit vegetables or funding community exercise facilities, respectively. If...
You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging/Surveillance II (MP51)1 May 2024MP51-07 UTILITY AND PRACTICABILITY OF NEPHROMETRY SCORING SYSTEMS IN CONTEMPORARY CLINICAL PRACTICE–AN INTERNATIONAL MULTICENTRE PERSPECTIVE Brendan A. Yanada, Fitzroy, Australia, H. Dias, Niall M. Corcoran, Nathan Lawrentschuk, Ravindra Sabnis, Jeremy Y. C. Teoh, and Dinesh Agarwal YanadaBrendan Yanada , Fitzroy Australia DiasBrendan Dias CorcoranNiall Corcoran...
There are a variety of medical and surgical treatment options available today for the management lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction due benign prostatic hyperplasia (BPH).
The incidence of nonmetastatic castrate resistant prostate cancer (nmCRPC) is not well defined in contemporary practice. aim this study to describe the and patterns treatment nmCRPC over last 6 years at a single high-volume Australian health institution.
Abstract Objective We determined the optimal timing for initiating androgen receptor signaling inhibitor (ARSI) therapy in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) and assessed its impact on oncological outcomes. Materials methods This retrospective study included 145 nmCRPC who received enzalutamide, apalutamide or darolutamide at Jikei University Hospital affiliated institutions between May 2014 November 2022. Patients were stratified based...
To compare adverse event (AE) profiles between patients with prostate cancer receiving triplet therapy (docetaxel, androgen receptor signaling inhibitors [ARSIs], and deprivation [ADT]) those docetaxel-based (docetaxel ADT). Additionally, we sought to identify risk factors for severe AEs associated these treatment regimens. In this retrospective, multicenter study, included 359 diagnosed metastatic castration-sensitive (mCSPC) or castration-resistant (mCRPC) who were treated docetaxel. We...
We present a case of self-insertion multiple button batteries into the urethra. Button are corrosive and tissue liquefaction necrosis can occur within 2 hours. Emergent removal, intravenous antibiotics, suprapubic indwelling catheter insertion close monitoring required to prevent further injury. In our case, were removed with stent grasper forceps. There was extensive caustic circumferential injury urethral mucosa on cystoscopic examination. This complicated by periurethral abscess,...
The enhanced recovery after surgery (ERAS) protocol for radical cystectomy aims to facilitate postoperative and hasten a return normal daily activities. This study report on the perioperative outcomes of implementation an ERAS at single Australian institution.
Primary bladder amyloidosis, a mimicker of malignancy, is rare but important differential diagnosis for patients presenting with haematuria. We report the case 58-year-old man who initially presented macroscopic haematuria and irritative urinary tract symptoms. There was no radiological evidence mass lesion, cystoscopy revealed an erythematous papillary lesion in posterior wall concerning malignancy. Histology demonstrated primary which completely excised intraoperatively. He undergoing...
Abstract Introduction and Objectives The Enhanced Recovery After Surgery (ERAS) protocol for radical cystectomy aims to facilitate postoperative recovery hasten a return normal daily activities. This study report on the perioperative outcomes of implementation an ERAS at single Australian institution. Methods We identified 73 patients with pT1 – T4 bladder cancer who underwent open Western Health, Victoria between June 2016 August 2021. A retrospective analysis prospectively maintained...